Author

Huang Qiu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anastasiya Redkina· 1 shared Christopher G. ParkeriD· 1 shared Enrique SáeziD· 1 shared Gabriel C. LanderiD· 1 shared H. Michael PetrassiiD· 1 shared Jeffrey T. MindreboiD· 1 shared Justyna SosnaiD· 1 shared Kıvanç BirsoyiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Anastasiya Redkina

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacological Inhibition of SLC33A1 Promotes Endoplasmic Reticulum Hyperoxidation and Induces Adaptive IRE1/XBP1s Signaling

Sergei Kutseikin, Maria Rafiq, Prerona Bora, Shanshan Liu, Rick A. Homan, Jeffrey T. Mindrebo, Matthew Holcomb, H. Michael Petrassi, Huang Qiu, Anastasiya Redkina, Justyna Sosna, Thanh-Trang Lee, Xiao Hu, Stefano Forli, Christopher G. Parker, , Luke Wiseman

This study shows that IXA4 inhibits SLC33A1, causing ER hyperoxidation and activating IRE1/XBP1s signaling, which reduces viability of KEAP1-deficient lung cancer cells.

bioRxiv · Feb 18, 2026 · PreprintCell Biology